A new scoping review looked at the range of non-drug treatments studied for movement problems in Parkinson's disease. It included 50 reports covering 48 separate randomized trials. The treatments studied included rehabilitation, technology-assisted training, mind-body or exercise-based approaches, acupuncture-related or manual approaches, neuromodulation, cueing, biofeedback, and other physical interventions.
The review found that this body of research is broad but very mixed in how it was done. Studies varied in size, how much treatment was given, what they were compared against, which movement symptoms were measured, how long people were followed, and how safety was reported. Because of this, the review does not show that any one treatment works better than another.
The review also did not report safety information, so it is not possible to say from this work whether these treatments are safe or well tolerated.
The main message is that many non-drug options have been studied for Parkinson's movement symptoms, but the evidence is not yet strong enough to say which ones help most. People with Parkinson's should talk with their doctor about their care.
Common questions
What did this review find about non-drug treatments for Parkinson's?
It found that 48 randomized trials have studied many non-drug approaches, such as exercise, rehabilitation, and technology-assisted training. But the studies were very different from each other, so the review could not show which treatments work better than others. It maps the research landscape rather than proving what helps most.
Does this mean exercise or other non-drug treatments do not work for Parkinson's?
No. The review does not say these treatments fail. It says the evidence is too mixed to compare them or make recommendations. Many of these approaches have been studied, but differences in study design, treatment dose, and outcomes make it hard to draw firm conclusions about which is best.
Were side effects or safety concerns reported in this review?
No safety information was reported in this review. It did not include data on side effects, serious events, or how well people tolerated the treatments. Because of that, this review cannot tell you whether these non-drug approaches are safe or not. Ask your doctor about safety for any specific treatment.
Why can't this review say which Parkinson's treatment is best?
The 48 trials varied widely in size, treatment dose, what they compared against, which motor symptoms they measured, follow-up length, and safety reporting. This heterogeneity means the results cannot be combined to rank treatments. The review maps where research exists but does not establish comparative efficacy or justify treatment recommendations.
